A

Athenex Inc
F:2MT

Watchlist Manager
Athenex Inc
F:2MT
Watchlist
Price: 0.12 EUR Market Closed
Market Cap: 715.7m EUR

Wall Street
Price Targets

2MT Price Targets Summary
Athenex Inc

There are no price targets for 2MT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Athenex Inc Competitors:
Price Targets
TLX
Telix Pharmaceuticals Ltd
35% Upside
BINV
BioInvent International AB
136% Upside
MNKD
MannKind Corp
140% Upside
APGE
Apogee Therapeutics Inc
134% Upside
SPRO
Spero Therapeutics Inc
104% Upside
CYTK
Cytokinetics Inc
134% Upside
AUPH
Aurinia Pharmaceuticals Inc
26% Upside
ALT
Altimmune Inc
297% Upside

Revenue
Forecast

Revenue Estimate
Athenex Inc

For the last 7 years the compound annual growth rate for Athenex Inc's revenue is 33%. The projected CAGR for the next 2 years is 2%.

33%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Athenex Inc

Operating Income forecast
is not available for
Athenex Inc

Net Income
Forecast

Net Income Estimate
Athenex Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 2MT's stock price target?
Not Available

2MT doesn't have any price targets made by Wall Street professionals.

What is Athenex Inc's Revenue forecast?
Projected CAGR
2%

For the last 7 years the compound annual growth rate for Athenex Inc's revenue is 33%. The projected CAGR for the next 2 years is 2%.

Back to Top